Advertisement

Tumor Biology

, Volume 35, Issue 11, pp 10707–10714 | Cite as

FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway

  • Li Zhang
  • Handong Wang
  • Jianhong Zhu
  • Ke Ding
  • Jianguo Xu
Research Article

Abstract

2-Amino-2-[2-(4-octylphenyl)]-1,3-propanediol hydrochloride (FTY720), a synthetic compound from Isaria sinclairii, has been proven to possess various biological benefits including anti-cancer activity. However, the effects and related mechanisms of FTY720 on the migration and invasion of glioblastoma cells are still unclear. In the present study, we utilized U251MG and U87MG human glioblastoma cell lines to assess the effects of FTY720. We found that FTY720 significantly inhibited migration and invasion of glioblastoma cells. The anti-migration and invasion effects of FTY720 were associated with its down-regulation of matrix metalloproteinase-2 (MMP-2) and MMP-9 while up-regulation of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, FTY720 modulated the expression of roundabouts 1 (ROBO1), Rho-associated kinase-1 (ROCK1), and epithelial-to-mesenchymal transition (EMT)-related factors. In addition, the phosphatidylinositide 3-kinases/protein kinase B/mammalian target of rapamycin/p70S6 kinase (PI3K/AKT/mTOR/p70S6K) signaling pathway participated in FTY720-mediated suppression of migration and invasion. Thus, our findings demonstrated that FTY720 reduced glioblastoma cells migration and invasion via multiple signaling pathways, suggesting that FTY720 is a potential therapeutic agent against glioblastoma.

Keywords

FTY720 Glioblastoma Invasion Migration PI3K/AKT/mTOR/p70S6K 

Notes

Acknowledgments

This work was supported by Grants from the National Natural Science Foundation of China (No. 81070974 & No. 81271377), the Jiangsu Provincial Key Subject (no. X4200722), and Jinling Hospital of Nanjing, China (no. 2010Q017).

Conflicts of interest

None

References

  1. 1.
    Meyer MA. Malignant gliomas in adults. N Engl J Med. 2008;359:1850.PubMedGoogle Scholar
  2. 2.
    Zhang L, Wang H, Xu J, Zhu J, Ding K. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 2014;228:248–59.PubMedCrossRefGoogle Scholar
  3. 3.
    Ji X, Wang H, Zhu J, Zhu L, Pan H, Li W, et al. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Int J Cancer. 2014;135:574–84.PubMedCrossRefGoogle Scholar
  4. 4.
    Shen Y, Cai M, Xia W, Liu J, Zhang Q, Xie H, et al. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Cancer Lett. 2007;254:288–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhang L, Wang HD, Ji XJ, Cong ZX, Zhu JH, Zhou Y. FTY720 for cancer therapy (Review). Oncol Rep. 2013;30:2571–8.PubMedGoogle Scholar
  6. 6.
    Zhang N, Qi Y, Wadham C, Wang L, Warren A, Di W, et al. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy. 2010;6:1157–67.PubMedCrossRefGoogle Scholar
  7. 7.
    Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy. 2011;7:707–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, et al. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Cancer Res. 2005;65:7478–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y, et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res. 2002;62:1410–9.PubMedGoogle Scholar
  10. 10.
    Li CX, Shao Y, Ng KT, Liu XB, Ling CC, Ma YY, et al. FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PLoS One. 2012;7:e32380.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Schmid G, Guba M, Papyan A, Ischenko I, Bruckel M, Bruns CJ, et al. FTY720 inhibits tumor growth and angiogenesis. Transplant Proc. 2005;37:110–1.PubMedCrossRefGoogle Scholar
  12. 12.
    Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, et al. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J Cell Biochem. 2007;101:259–70.PubMedCrossRefGoogle Scholar
  13. 13.
    Pan H, Wang H, Zhu L, Mao L, Qiao L, Su X. The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg. 2013;80:363–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Subramani R, Lopez-Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS One. 2014;9:e97016.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Liu C, Shi X, Wang L, Wu Y, Jin F, Bai C, et al. SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. Tumour Biol. 2014;35:6073–82.PubMedCrossRefGoogle Scholar
  16. 16.
    Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68:3645–54.PubMedCrossRefGoogle Scholar
  17. 17.
    Kim YS, Lee HA, Lim JY, Kim Y, Jung CH, Yoo SH, et al. beta-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1alpha. J Nutr Biochem. 2014;25:655–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, et al. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2–9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Hum Exp Toxicol. 2011;30:406–15.PubMedCrossRefGoogle Scholar
  19. 19.
    Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267–83.PubMedCrossRefGoogle Scholar
  20. 20.
    Kiesslich T, Pichler M, Neureiter D. Epigenetic control of epithelial-mesenchymal-transition in human cancer. Mol Clin Oncol. 2013;1:3–11.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Gheldof A, Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci. 2013;116:317–36.PubMedCrossRefGoogle Scholar
  22. 22.
    Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol. 2008;33:585–93.PubMedGoogle Scholar
  23. 23.
    Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 2009;28:65–76.PubMedCrossRefGoogle Scholar
  24. 24.
    Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Durst M, et al. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer. 2006;5:16.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Singh RK, Indra D, Mitra S, Mondal RK, Basu PS, Roy A, et al. Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Hum Genet. 2007;122:71–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Gilkes DM, Xiang L, Lee SJ, Chaturvedi P, Hubbi ME, Wirtz D, et al. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc Natl Acad Sci U S A. 2014;111:E384–93.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Wang J, Liu XH, Yang ZJ, Xie B, Zhong YS. The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells. BMC Cancer. 2014;14:89.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Dontula R, Dinasarapu A, Chetty C, Pannuru P, Herbert E, Ozer H, et al. MicroRNA 203 modulates glioma cell migration via Robo1/ERK/MMP-9 signaling. Genes Cancer. 2013;4:285–96.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Gohrig A, Detjen KM, Hilfenhaus G, Korner JL, Welzel M, Arsenic R, et al. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res. 2014;74:1529–40.PubMedCrossRefGoogle Scholar
  30. 30.
    Sun H, Wang Z, Yakisich JS. Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticancer Agents Med Chem. 2013;13:1048–56.PubMedCrossRefGoogle Scholar
  31. 31.
    Yuan L, Wei S, Wang J, Liu X. Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells. J Agric Food Chem. 2014;62:5390–400.PubMedCrossRefGoogle Scholar
  32. 32.
    Ren W, Liu Y, Wan S, Fei C, Wang W, Chen Y, et al. BMP9 Inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways. PLoS One. 2014;9:e96816.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Li Zhang
    • 1
  • Handong Wang
    • 1
  • Jianhong Zhu
    • 1
  • Ke Ding
    • 1
  • Jianguo Xu
    • 1
  1. 1.Department of Neurosurgery, Jinling Hospital, School of MedicineNanjing UniversityNanjingChina

Personalised recommendations